DK1545553T3 - Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter - Google Patents

Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter

Info

Publication number
DK1545553T3
DK1545553T3 DK03766336.6T DK03766336T DK1545553T3 DK 1545553 T3 DK1545553 T3 DK 1545553T3 DK 03766336 T DK03766336 T DK 03766336T DK 1545553 T3 DK1545553 T3 DK 1545553T3
Authority
DK
Denmark
Prior art keywords
alkylphosphocholines
combination
antitumor drugs
antitumor
drugs
Prior art date
Application number
DK03766336.6T
Other languages
Danish (da)
English (en)
Inventor
Herbert Sindermann
Juergen Engel
Eckhard Guenther
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Application granted granted Critical
Publication of DK1545553T3 publication Critical patent/DK1545553T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03766336.6T 2002-07-30 2003-07-29 Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter DK1545553T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39961502P 2002-07-30 2002-07-30
PCT/EP2003/008346 WO2004012744A1 (de) 2002-07-30 2003-07-29 Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten

Publications (1)

Publication Number Publication Date
DK1545553T3 true DK1545553T3 (da) 2011-09-12

Family

ID=31495746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03766336.6T DK1545553T3 (da) 2002-07-30 2003-07-29 Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter

Country Status (26)

Country Link
US (3) US8389497B2 (OSRAM)
EP (2) EP1545553B1 (OSRAM)
JP (1) JP2005535688A (OSRAM)
KR (3) KR20110102485A (OSRAM)
CN (1) CN1302780C (OSRAM)
AR (1) AR040717A1 (OSRAM)
AT (1) ATE516036T1 (OSRAM)
AU (2) AU2003253350B2 (OSRAM)
BR (1) BR0313048A (OSRAM)
CA (1) CA2493023C (OSRAM)
CY (1) CY1111902T1 (OSRAM)
DK (1) DK1545553T3 (OSRAM)
ES (1) ES2369535T3 (OSRAM)
HR (1) HRP20050184B1 (OSRAM)
IL (1) IL166329A (OSRAM)
MX (1) MXPA05001203A (OSRAM)
NO (1) NO335196B1 (OSRAM)
NZ (1) NZ538428A (OSRAM)
PL (1) PL375493A1 (OSRAM)
PT (1) PT1545553E (OSRAM)
RU (1) RU2005105693A (OSRAM)
SI (1) SI1545553T1 (OSRAM)
TW (1) TWI332007B (OSRAM)
UA (1) UA82322C2 (OSRAM)
WO (1) WO2004012744A1 (OSRAM)
ZA (1) ZA200500453B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ538428A (en) 2002-07-30 2006-09-29 Zentaris Gmbh Use of alkylphosphocholines in combination with antitumor medicaments
US8383605B2 (en) 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
DE10324911B4 (de) 2003-05-30 2005-08-18 Siemens Ag Röntgenvorrichtung mit partiellem digitalem Detektor und Verfahren zum Betrieb einer solchen
WO2006081452A2 (en) * 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
KR101378005B1 (ko) 2005-12-19 2014-03-27 아에테르나 젠타리스 게엠베하 세포독성이 감소된 알킬 인지질 유도체 및 이의 용도
US20070167408A1 (en) * 2005-12-19 2007-07-19 Zentaris Gmbh Novel alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
US8703179B2 (en) 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
KR20100092424A (ko) * 2007-07-30 2010-08-20 아디아 바이오사이언스즈 인크. 다형체를 포함하는, ｍｅｋ의 억제제로서의 ｎ-(아릴아미노) 술폰아미드의 유도체 및 조성물, 사용 방법 및 이의 제조 방법
AU2009324464B2 (en) * 2008-12-11 2016-05-05 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
CA2794513A1 (en) 2010-03-31 2011-10-06 Aeterna Zentaris Gmbh Perifosine and capecitabine as a combined treatment for cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59205998D1 (de) * 1991-07-04 1996-05-23 Asta Medica Ag Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
US5942639A (en) * 1991-07-04 1999-08-24 Asta Medica Aktiengesellschaft Process for the preparation of alkylphosphocholines and the production thereof in pure form
US6172050B1 (en) * 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
JP3079993B2 (ja) * 1996-03-27 2000-08-21 日本電気株式会社 真空マイクロデバイスおよびその製造方法
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
SK284839B6 (sk) 1998-01-22 2005-12-01 Zentaris Gmbh Použitie miltefozínu na výrobu lieku a farmaceutická kombinácia na liečenie leishmanózy
EP1135193B1 (de) * 1998-12-04 2002-10-30 Max-Delbrück-Centrum Für Molekulare Medizin Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten
JP2002532553A (ja) * 1998-12-21 2002-10-02 インケイサ．ソシエダ アノニマ 有害な胃腸副作用を引き起こさない有力な抗炎症剤としてのエーテルリゾリン脂質の使用
LT3351246T (lt) * 2001-02-19 2019-07-10 Novartis Pharma Ag Rapamicino darinys, skirtas kieto naviko, susijusio su nereguliuojama angiogeneze, gydymui
DE60234577D1 (de) * 2001-03-23 2010-01-14 Shire Canada Inc Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
WO2003005522A1 (es) 2001-07-04 2003-01-16 Acuna Arturo Tapones para sellado de ductos para redes electricas, telefonicas y de fibra optica.
DK1461083T3 (da) * 2002-01-02 2006-07-10 Nerviano Medical Sciences Srl Kombineret terapi mod tumorer omfattende substitueret acryloyl distamycinderivater og proteinkinase- (serin/threoninkinase) inhibitorer
NZ538428A (en) 2002-07-30 2006-09-29 Zentaris Gmbh Use of alkylphosphocholines in combination with antitumor medicaments
WO2005000318A2 (en) * 2003-06-23 2005-01-06 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
WO2006081452A2 (en) 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
US20070167408A1 (en) * 2005-12-19 2007-07-19 Zentaris Gmbh Novel alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
CA2794513A1 (en) 2010-03-31 2011-10-06 Aeterna Zentaris Gmbh Perifosine and capecitabine as a combined treatment for cancer

Also Published As

Publication number Publication date
EP1545553B1 (de) 2011-07-13
CA2493023A1 (en) 2004-02-12
TW200404073A (en) 2004-03-16
US8389497B2 (en) 2013-03-05
AU2008203060B2 (en) 2011-04-21
ATE516036T1 (de) 2011-07-15
HK1080751A1 (en) 2006-05-04
BR0313048A (pt) 2005-06-14
KR20130016413A (ko) 2013-02-14
PL375493A1 (en) 2005-11-28
NO20051040L (no) 2005-02-25
RU2005105693A (ru) 2005-07-10
MXPA05001203A (es) 2005-06-08
CY1111902T1 (el) 2015-11-04
US8507710B2 (en) 2013-08-13
TWI332007B (en) 2010-10-21
KR20050026028A (ko) 2005-03-14
EP1545553A1 (de) 2005-06-29
IL166329A0 (en) 2006-01-15
UA82322C2 (uk) 2008-04-10
AR040717A1 (es) 2005-04-20
AU2008203060A1 (en) 2008-07-31
US20100190738A1 (en) 2010-07-29
US20040097470A1 (en) 2004-05-20
WO2004012744A1 (de) 2004-02-12
IL166329A (en) 2012-08-30
KR20110102485A (ko) 2011-09-16
KR101066804B1 (ko) 2011-09-22
CN1671397A (zh) 2005-09-21
AU2003253350B2 (en) 2008-06-26
SI1545553T1 (sl) 2011-09-30
ES2369535T3 (es) 2011-12-01
HRP20050184A2 (en) 2005-04-30
PT1545553E (pt) 2011-09-12
NZ538428A (en) 2006-09-29
US8551977B2 (en) 2013-10-08
HRP20050184B1 (hr) 2014-04-11
EP2301551A1 (de) 2011-03-30
ZA200500453B (en) 2005-08-31
US20100189784A1 (en) 2010-07-29
AU2003253350A1 (en) 2004-02-23
NO335196B1 (no) 2014-10-20
CN1302780C (zh) 2007-03-07
CA2493023C (en) 2012-01-31
JP2005535688A (ja) 2005-11-24

Similar Documents

Publication Publication Date Title
NO2024034I1 (no) Elvitegravir and tenofovir alafenamide
EP1682989A4 (en) SYNCHRONIZATION AND FUSION ENGINES
DK2609948T3 (da) Infusionsindretning i form af plaster
DK1622880T3 (da) Substituerede dihydroquinazoliner med antivirale egenskaber
DE60327864D1 (de) Ballondissektor mit kanüle
DE602004004953D1 (de) Kochfeld mit Benutzerschnittstelle und beliebiger Positionierung
DK1581297T3 (da) Kateter med enhedsbestanddel
EE200200607A (et) 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
ATE512148T1 (de) Pyrazolo- und imidazopyrimidinderivate
NO20043313L (no) Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner
IS8529A (is) Rífamísínhliðstæður og notkun þeirra
NO20053529D0 (no) Lymfotoksin-beta-reseptormedikamenter i kombinasjon med kjemoterapeutiske midler
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DK1545553T3 (da) Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter
PL377180A1 (pl) Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz
DK1541137T3 (da) Transdermalt delivery system af gestoden
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DE602005024291D1 (de) Kamerasystem und kamera-hauptkörper
DK1603919T3 (da) 7-Iminoderivater af camptothecin med antitumoraktivitet
PT1865966E (pt) Uso de fármacos anti-inflamatórios não esteróides por inalação no tratamento de bronquite aguda e crónica
DE602005008394D1 (de) Mehrfach-lampenbeleuchtungssystem mit polarisationswiederherstellung und integration
DK1713461T3 (da) Forbindelser med antitumor-virkning
FI20040750A0 (fi) Prepreg ja sen käyttö
FI20041145L (fi) Kaivo ja liitos
DE502004010917D1 (de) Rstellung und verwendung